Genetics of osteoporosis

Endocrine Reviews

Volumn 31, Issue 5, 2010, Pages 629-662

  Ralston, Stuart H ^a   Uitterlinden, André G ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS18 PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COL1A1 PROTEIN; CRHR1 PROTEIN; ESR1 PROTEIN; ESTROGEN; FLJ42280 PROTEIN; GLUCOCORTICOID; HISTONE DEACETYLASE 5; MADS BOX TRANSCRIPTION ENHANCER FACTOR 2,POLYPEPTIDE C; MARK3 PROTEIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MEMBRANE PROTEIN; METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTNNB1; TRANSCRIPTION FACTOR SOX6; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

AGE DISTRIBUTION; BONE DEFECT; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; BONE TISSUE; BONE TURNOVER; CAMURATI ENGELMANN DISEASE; DCDC1 GENE; DCDC5 GENE; DIET; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXERCISE; FAM3C GENE; FAMILY STUDY; FOXC2 GENE; FOXL1 GENE; FRAGILITY FRACTURE; GENE; GENE CONTROL; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GEOMETRY; GPR177 GENE; HERITABILITY; HIGH BONE MASS SYNDROME; HORMONE SUBSTITUTION; HUMAN; LINKAGE ANALYSIS; LIPOPROTEIN RECEPTOR RELATED PROTEIN 4 GENE; LRP5 GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MENDELIAN OSTEOPOROSIS SYNDROME; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PHENOTYPE; PLAY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SFRP4 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOST GENE; SPTBN1 GENE; STARD3NL GENE; TREATMENT RESPONSE; TWINS; ULTRASOUND; ZBTB40 GENE;

ANIMALS; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OSTEOPOROSIS; QUANTITATIVE TRAIT LOCI;

EID: 77957131317     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0044     Document Type: Review

References (262)

1. Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
2. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM 2001 Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815-2822 (Pubitemid 33126923)
3. Sigurdsson G, Halldorsson BV, Styrkarsdottir U, Kristjansson K, Stefansson K 2008 Impact of genetics on low bone mass in adults. J Bone Miner Res 23:1584-1590
4. Torgerson DJ, Campbell MK, Thomas RE, Reid DM 1996 Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 11:293-297 (Pubitemid 26054186)
5. Boyce BF, Xing L 2008 Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146
6. Johnson ML, Harnish K, Nusse R, Van Hul W 2004 LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19:1749-1757 (Pubitemid 41103424)
7. Glass 2nd DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764 (Pubitemid 40585297)
8. Krishnan V, Bryant HU, Macdougald OA 2006 Regulation of bone mass by Wnt signaling. J Clin Invest 116:1202-1209
9. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH 2008 Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283:5866-5875
10. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317 (Pubitemid 35345151)
11. van't Hof RJ, Macphee J, Libouban H, Helfrich MH, Ralston SH 2004 Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145:5068-5074 (Pubitemid 39551126)
12. Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH 2005 Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11:774-779
13. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I 2006 Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103:696-701 (Pubitemid 43153088)
14. Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, van't Hof RJ, Ralston SH 2009 Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab 10:139-147
15. Ralston SH, de'Lara G, Farquhar DJ, Gallacher SJ, Hannan J, McLellan AR 2009 NICE on osteoporosis. Women over 75 with fragility fractures should have DEXA. BMJ 338:b2340
16. De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA 1997 Bone density and risk of hip fracture in men and women: cross sectional analysis [Erratum (1997) 315:916]. BMJ 315: 221-225
17. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538 (Pubitemid 26331009)
18. Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774 (Pubitemid 23127383)
19. Faulkner KG, Cummings SR, Black D, Palermo L, Glüer CC, Genant HK 1993 Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 8:1211-1217 (Pubitemid 23308114)
20. Leslie WD, Pahlavan PS, Tsang JF, Lix LM 2009 Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int 20:1767-1774
21. El-Kaissi S, Pasco JA, Henry MJ, Panahi S, Nicholson JG, Nicholson GC, Kotowicz MA 2005 Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study. Osteoporos Int 16:1299-1303 (Pubitemid 41396960)
22. Cummings SR, Cauley JA, Palermo L, Ross PD, Wasnich RD, Black D, Faulkner KG 1994 Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of Osteoporotic Fractures Research Group. Osteoporos Int 4:226-229
23. Slemenda CW, Turner CH, Peacock M, Christian JC, Sorbel J, Hui SL, Johnston CC 1996 The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos Int 6:178-182
24. Smith DM, Nance WE, Kang KW, Christian JC, Johnston Jr CC 1973 Genetic factors in determining bone mass. J Clin Invest 52:2800-2808
25. Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 12:2017-2022
26. Krall EA, Dawson-Hughes B 1993 Heritable and life-style determinants of bone mineral density. J Bone Miner Res 8:1-9
27. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston Jr CC 1991 Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 6:561-567
28. Arden NK, Baker J, Hogg C, Baan K, Spector TD 1996 The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530-534
29. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706-710
30. Hansen MA, Hassager C, Jensen SB, Christiansen C 1992 Is heritability a risk factor for postmenopausal osteoporosis? J Bone Miner Res 7:1037-1043
31. Makovey J, Nguyen TV, Naganathan V, Wark JD, Sambrook PN 2007 Genetic effects on bone loss in periand postmenopausal women: a longitudinal twin study. J Bone Miner Res 22:1773-1780
32. Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman J 1993 Changes in axial bone density with age: a twin study. J Bone Miner Res 8:11-17
33. Shaffer JR, Kammerer CM, Bruder JM, Cole SA, Dyer TD, Almasy L, MacCluer JW, Blangero J, Bauer RL, Mitchell BD 2008 Genetic influences on bone loss in the San Antonio Family Osteoporosis study. Osteoporos Int 19:1759-1767
34. Snieder H, MacGregor AJ, Spector TD 1998 Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 83:1875-1880
35. Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Estrada K, Rivadeneira F, Williams FM, Cherkas L, Deloukas P, Soranzo N, de Keyzer JJ, Pop VJ, Lips P, Lebrun CE, van der Schouw YT, Grobbee DE, Witteman J, Hofman A, Pols HA, Laven JS, Spector TD, Uitterlinden AG 2009 Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 41:645-647
36. Christian JC, Yu PL, Slemenda CW, Johnston Jr CC 1989 Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 44:429-433
37. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773
38. Deng HW, Chen WM, Recker S, Stegman MR, Li JL, Davies KM, Zhou Y, Deng H, Heaney R, Recker RR 2000 Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J Bone Miner Res 15:1243-1252
39. Andrew T, Antioniades L, Scurrah KJ, Macgregor AJ, Spector TD 2005 Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J Bone Miner Res 20:67-74
40. Kannus P, Palvanen M, Kaprio J, Parkkari J, Koskenvuo M 1999 Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins. BMJ 319:1334-1337
41. Michaëlsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL 2005 Genetic liability to fractures in the elderly. Arch Intern Med 165:1825-1830
42. Xiong DH, Shen H, Xiao P, Guo YF, Long JR, Zhao LJ, Liu YZ, Deng HY, Li JL, Recker RR, Deng HW 2006 Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J Bone Miner Res 21:424-437
43. Arden NK, Spector TD 1997 Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res 12:2076-2081
44. Kaprio J, Rimpelä A, Winter T, Viken RJ, Rimpelä M, Rose RJ 1995 Common genetic influences on BMI and age at menarche. Hum Biol 67:739-753
45. Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD 2001 Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16:371-378
46. Garnero P, Arden NK, Griffiths G, Delmas PD, Spector TD 1996 Genetic influence on bone turnover in postmenopausal twins. J Clin Endocrinol Metab 81:140-146
47. Deng HW, Livshits G, Yakovenko K, Xu FH, Conway T, Davies KM, Deng H, Recker RR 2002 Evidence for a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. Ann Hum Genet 66:61-74
48. Vidal C, Galea R, Brincat M, Anastasi AX 2007 Linkage to chromosome 11p12 in two Maltese families with a highly penetrant form of osteoporosis. Eur J Hum Genet 15:800-809
49. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH 2007 Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209-221
50. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC 2006 Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355:2757-2764
51. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC 2007 Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39:359-365 (Pubitemid 46328489)
52. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC 2010 Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 362: 521-528
53. Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML 1996 Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet 59:146-151
54. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan- Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523
55. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
56. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
57. Johnson ML, Gong G, Kimberling W, Reckér SM, Kimmel DB, Recker RB 1997 Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 60:1326-1332
58. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Bénichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W 2003 Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763-771 (Pubitemid 36255977)
59. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19
60. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521 (Pubitemid 34755690)
61. Balemans W, Cleiren E, Siebers U, Horst J, Van Hul W 2005 A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. Bone 36:943-947 (Pubitemid 40797994)
62. Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W 2002 Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91-97 (Pubitemid 34146376)
63. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W 2001 Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537-543
64. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J 2001 Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589
65. Gardner JC, van Bezooijen RL, Mervis B, Hamdy NA, Lö wik CW, Hamersma H, Beighton P, Papapoulos SE 2005 Bone mineral density in sclerosteosis; affected individuals and gene carriers. J Clin Endocrinol Metab 90:6392-6395
66. Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C 2009 Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 84:1-12
67. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, Coxon FP, Helfrich MH, Crockett JC, Mellis D, Vellodi A, Tezcan I, Notarangelo LD, Rogers MJ, Vezzoni P, Villa A, Frattini A 2008 Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 83:64-76
68. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH 2007 Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39:960-962
69. Balemans W, Van Wesenbeeck L, Van Hul W 2005 A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int 77:263-274
70. Janssens K, Gershoni-Baruch R, Guañabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W 2000 Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease. Nat Genet 26:273-275
71. Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC, Taniguchi N, Niikawa N, Yoshiura K 2000 Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19-20
72. Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W 2003 Transforming growth factor β-1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278:7718-7724
73. McGowan NW, MacPherson H, Janssens K, Van Hul W, Frith JC, Fraser WD, Ralston SH, Helfrich MH 2003 A mutation affecting the latency-associated peptide of TGFβ1 in Camurati-Engelmann disease enhances osteoclast formation in vitro. J Clin Endocrinol Metab 88:3321-3326 (Pubitemid 36877511)
74. Sawcer SJ, Maranian M, Singlehurst S, Yeo T, Compston A, Daly MJ, De Jager PL, Gabriel S, Hafler DA, Ivinson AJ, Lander ES, Rioux JD, Walsh E, Gregory SG, Schmidt S, Pericak-Vance MA, Barcellos L, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL 2004 Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. Hum Mol Genet 13:1943-1949
75. Almasy L, Blangero J 1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211 (Pubitemid 28199022)
76. Abecasis GR, Cherny SS, Cookson WO, Cardon LR 2002 Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101
77. Devoto M, Spotila LD, Stabley DL, Wharton GN, Rydbeck H, Korkko J, Kosich R, Prockop D, Tenenhouse A, Sol-Church K 2005 Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density. Eur J Hum Genet 13:781-788 (Pubitemid 40846851)
78. Tang ZH, Xiao P, Lei SF, Deng FY, Zhao LJ, Deng HY, Tan LJ, Shen H, Xiong DH, Recker RR, Deng HW 2007 A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis. J Clin Endocrinol Metab 92:2751-2757 (Pubitemid 47037386)
79. Nyholt DR 2000 All LODs are not created equal. Am J Hum Genet 67:282-288
80. Flint J, Valdar W, Shifman S, Mott R 2005 Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6:271-286 (Pubitemid 40469047)
81. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, Cookson WO, Taylor MS, Rawlins JN, Mott R, Flint J 2006 Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet 38:879-887 (Pubitemid 44141655)
82. Grupe A, Germer S, Usuka J, Aud D, Belknap JK, Klein RF, Ahluwalia MK, Higuchi R, Peltz G 2001 In silico mapping of complex disease-related traits in mice. Science 292:1915-1918
83. Velasco J, Zarrabeitia MT, Prieto JR, Perez-Castrillon JL, Perez-Aguilar MD, Perez-Nuñez MI, Sañudo C, Hernandez-Elena J, Calvo I, Ortiz F, Gonzalez-Macias J, Riancho JA 2010 Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos Int 21:109-118
84. Tenne M, McGuigan F, Jansson L, Gerdhem P, Obrant KJ, Luthman H, Akesson K 2008 Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42:719-727
85. Spielman RS, McGinnis RE, Ewens WJ 1993 Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516
86. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, Clayton DG, McKeigue PM 2003 Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72:1492-1504 (Pubitemid 36628388)
87. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, Maraganore DM, Bishop JA, O'Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AG, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ 2005 A network of investigator networks in human genome epidemiology. Am J Epidemiol 162:302-304
88. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371:1505-1512
89. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Snorradóttir S, Center JR, Nguyen TV, Alexandersen P, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K 2009 New sequence variants associated with bone mineral density. Nat Genet 41:15-17
90. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K 2008 Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355-2365
91. Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D 2007 Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S14 (Pubitemid 351935127)
92. Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, Sha BY, Tang ZH, Pan F, Yang TL, Chen XD, Lei SF, Yerges LM, Zhu XZ, Wheeler VW, Patrick AL, Bunker CH, Guo Y, Yan H, Pei YF, Zhang YP, Levy S, Papasian CJ, Xiao P, Lundberg YW, Recker RR, Liu YZ, Liu YJ, Zmuda JM, Deng HW 2009 Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 84:388-398
93. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Lee JK, Oh B, Kim HL 2009 A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41:527-534
94. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P 2009 Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752
95. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP 2008 Meta-analysis methods. Adv Genet 60:311-334
96. Rivadeneira F, Styrkársdottir U, Estrada K, Halldórsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Grundberg E, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra B, Pastinen T, Pols HA, Sigurdsson G, Soranzo N, Thorleifsson G, Thorsteinsdottir U, Williams FM, Wilson SG, Zhou Y, Ralston SH, van Duijn CM, Spector T, Kiel DP, Stefansson K, Ioannidis JP, Uitterlinden AG 2009 Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199-1206
97. Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng HW, Econs MJ, Karasik D, Devoto M, Kammerer CM, Spector T, Andrew T, Cupples LA, Duncan EL, Foroud T, Kiel DP, Koller D, Langdahl B, Mitchell BD, Peacock M, Recker R, Shen H, Sol-Church K, Spotila LD, Uitterlinden AG, Wilson SG, Kung AW, Ralston SH 2007 Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res 22:173-183
98. Ioannidis JP, Ntzani EE, Trikalinos TA 2004 'Racial' differences in genetic effects for complex diseases. Nat Genet 36:1312-1318
99. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889-894
100. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, Rüther U 2009 Inactivation of the Fto gene protects from obesity. Nature 458:894-898
101. Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ 2005 Sex-specific quantitative trait loci contribute to normal variation in bone structure at the proximal femur in men. Bone 37:467-473 (Pubitemid 41317319)
102. Koller DL, White KE, Liu G, Hui SL, Conneally PM, Johnston CC, Econs MJ, Foroud T, Peacock M 2003 Linkage of structure at the proximal femur to chromosomes 3, 7, 8, and 19. J Bone Miner Res 18:1057-1065
103. Deng HW, Shen H, Xu FH, Deng H, Conway T, Liu YJ, Liu YZ, Li JL, Huang QY, Davies KM, Recker RR 2003 Several genomic regions potentially containing QTLs for bone size variation were identified in a whole-genome linkage scan. Am J Med Genet 119A:121-131 (Pubitemid 37069229)
104. Demissie S, Dupuis J, Cupples LA, Beck TJ, Kiel DP, Karasik D 2007 Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study. Bone 40:743-750 (Pubitemid 46187216)
105. Wilson SG, Reed PW, Andrew T, Barber MJ, Lindersson M, Langdown M, Thompson D, Thompson E, Bailey M, Chiano M, Kleyn PW, Spector TD 2004 A genome-screen of a large twin cohort reveals linkage for quantitative ultrasound of the calcaneus to 2q33-37 and 4q12-21. J Bone Miner Res 19:270-277 (Pubitemid 38116741)
106. Karasik D, Myers RH, Hannan MT, Gagnon D, McLean RR, Cupples LA, Kiel DP 2002 Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genomewide linkage analysis. Osteoporos Int 13:796-802 (Pubitemid 36336724)
107. Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir VD, Sigurdardottir MS, Bagger Y, Christiansen C, Reynisdottir I, Grant SF, Jonasson K, Frigge ML, Gulcher JR, Sigurdsson G, Stefansson K 2003 Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 1:E69
108. Hsu YH, Xu X, Terwedow HA, Niu T, Hong X, Wu D, Wang L, Brain JD, Bouxsein ML, Cummings SR, Rosen CJ, Xu X 2007 Large-scale genome-wide linkage analysis for loci linked to BMD at different skeletal sites in extreme selected sibships. J Bone Miner Res 22:184-194 (Pubitemid 46167788)
109. Xiao P, Shen H, Guo YF, Xiong DH, Liu YZ, Liu YJ, Zhao LJ, Long JR, Guo Y, Recker RR, Deng HW 2006 Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res 21:1536-1544 (Pubitemid 44484597)
110. Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ 2009 Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. Bone 45:443-448
111. Kaufman JM, Ostertag A, Saint-Pierre A, Cohen-Solal M, Boland A, Van Pottelbergh I, Toye K, de Vernejoul MC, Martinez M 2008 Genome-wide linkage screen of bone mineral density (BMD) in European pedigrees ascertained through a male relative with low BMD values: evidence for quantitative trait loci on 17q21-23, 11q12-13, 13q12-14, and 22q11. J Clin Endocrinol Metab 93:3755-3762
112. Altmüller J, Palmer LJ, Fischer G, Scherb H, Wjst M 2001 Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 69:936-950 (Pubitemid 33015809)
113. Medici M, van Meurs JB, Rivadeneira F, Zhao H, Arp PP, Hofman A, Pols HA, Uitterlinden AG 2006 BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. J Bone Miner Res 21:845-854 (Pubitemid 43787991)
114. Koller DL, Liu G, Econs MJ, Hui SL, Morin PA, Joslyn G, Rodriguez LA, Conneally PM, Christian JC, Johnston Jr CC, Foroud T, Peacock M 2001 Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16:985-991 (Pubitemid 32467142)
115. Shaffer JR, Kammerer CM, Bruder JM, Cole SA, Dyer TD, Almasy L, Maccluer JW, Blangero J, Bauer RL, Mitchell BD 2009 Quantitative trait locus on chromosome 1q influences bone loss in young Mexican American adults. Calcif Tissue Int 84:75-84
116. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ 2001 Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16:1195-1206 (Pubitemid 32574647)
117. Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES 1998 Genetic analysis of bone mass in mice. J Bone Miner Res 13:1648-1656
118. Koller DL, Alam I, Sun Q, Liu L, Fishburn T, Carr LG, Econs MJ, Foroud T, Turner CH 2005 Genome screen for bone mineral density phenotypes in Fisher 344 and Lewis rat strains. Mamm Genome 16:578-586 (Pubitemid 41355920)
119. Havill LM, Mahaney MC, Cox LA, Morin PA, Joslyn G, Rogers J 2005 A quantitative trait locus for normal variation in forearm bone mineral density in pedigreed baboons maps to the ortholog of human chromosome 11q. J Clin Endocrinol Metab 90:3638-3645 (Pubitemid 41014337)
120. Turner CH, Sun Q, Schriefer J, Pitner N, Price R, Bouxsein ML, Rosen CJ, Donahue LR, Shultz KL, Beamer WG 2003 Congenic mice reveal sex-specific genetic regulation of femoral structure and strength. Calcif Tissue Int 73:297-303 (Pubitemid 37152892)
121. Alam I, Sun Q, Liu L, Koller DL, Fishburn T, Carr LG, Econs MJ, Foroud T, Turner CH 2005 Whole-genome scan for linkage to bone strength and structure in inbred Fischer 344 and Lewis rats. J Bone Miner Res 20:1589-1596 (Pubitemid 41243548)
122. Bouxsein ML, Rosen CJ, Turner CH, Ackert CL, Shultz KL, Donahue LR, Churchill G, Adamo ML, Powell DR, Turner RT, Muller R, Beamer WG 2002 Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. J Bone Miner Res 17:570-579 (Pubitemid 34246632)
123. Orwoll ES, Belknap JK, Klein RF 2001 Gender specificity in the genetic determinants of peak bone mass. J Bone Miner Res 16:1962-1971
124. Klein RF, Allard J, Avnur Z, Nikolcheva T, Rotstein D, Carlos AS, Shea M, Waters RV, Belknap JK, Peltz G, Orwoll ES 2004 Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303:229-232 (Pubitemid 38057572)
125. Ichikawa S, Koller DL, Johnson ML, Lai D, Xuei X, Edenberg HJ, Klein RF, Orwoll ES, Hui SL, Foroud TM, Peacock M, Econs MJ 2006 Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 21:556-564
126. Edderkaoui B, Baylink DJ, Beamer WG, Wergedal JE, Porte R, Chaudhuri A, Mohan S 2007 Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene. Genome Res 17:577-585 (Pubitemid 46715507)
127. Parsons CA, Mroczkowski HJ, McGuigan FE, Albagha OM, Manolagas S, Reid DM, Ralston SH, Shmookler Reis RJ 2005 Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. Hum Mol Genet 14:3141-3148 (Pubitemid 41631289)
128. Tang PL, Cheung CL, Sham PC, McClurg P, Lee B, Chan SY, Smith DK, Tanner JA, Su AI, Cheah KS, Kung AW, Song YQ 2009 Genome-wide haplotype association mapping in mice identifies a genetic variant in CER1 associated with BMD and fracture in southern Chinese women. J Bone Miner Res 24:1013-1021
129. Richards JB, Kavvoura FK, Rivadeneira F, Styrkársdóttir U, Estrada K, Halldórsson BV, Hsu YH, Zillikens MC, Wilson SG, Mullin BH, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra BA, Pols HA, Sigurdsson G, Thorsteinsdottir U, Soranzo N, Williams FM, Zhou Y, Ralston SH, Thorleifsson G, van Duijn CM, Kiel DP, Stefansson K, Uitterlinden AG, Ioannidis JP, Spector TD 2009 Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 151:528-537
130. Ralston SH, Uitterlinden AG, Brandi ML, Balcells S, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Scollen S, Bustamante M, Husted LB, Carey AH, Diez-Perez A, Dunning AM, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, del Monte F, Pols HA, Reeve J, Reid DM, Renner W, Rivadeneira F, van Schoor NM, Sherlock RE, Ioannidis JP 2006 Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS Study. PLoS Med 3:e90
131. Jin H, Wang X, Ying J, Wong AH, Li H, Lee KY, Srivastava G, Chan AT, Yeo W, Ma BB, Putti TC, Lung ML, Shen ZY, Xu LY, Langford C, Tao Q 2007 Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene 26:7490-7498 (Pubitemid 350158717)
132. Reiner O, Coquelle FM, Peter B, Levy T, Kaplan A, Sapir T, Orr I, Barkai N, Eichele G, Bergmann S 2006 The evolving doublecortin (DCX) superfamily. BMC Genomics 7:188
133. Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H 1995 Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Comm 217:378-383 (Pubitemid 26060487)
134. Sowers M, Willing M, Burns T, Deschenes S, Hollis B, Crutchfield M, Jannausch M 1999 Genetic markers, bone mineral density and serum osteocalcin levels. J Bone Miner Res 14:1411-1419 (Pubitemid 29368304)
135. Becherini L, Gennari L, Masi L, Mansani R, Massart F, Morelli A, Falchetti A, Gonnelli S, Fiorelli G, Tanini A, Brandi ML 2000 Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 9:2043-2050 (Pubitemid 30642669)
136. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306-311 (Pubitemid 26076380)
137. Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, Ouchi Y 1997 Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 21:379-383 (Pubitemid 27485305)
138. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L, Sirisriro R, Komindr S 1998 Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J Endocrinol Invest 21:487-493 (Pubitemid 28461691)
139. Albagha OM, McGuigan FE, Reid DM, Ralston SH 2001 Estrogen receptor α gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res 16:128-134
140. Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schuit SC, Hofman A, Helmerhorst TJ, van Leeuwen JP, Pols HA 1999 Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84:3146-3150
141. Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK 1997 Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women [see comments]. J Clin Endocrinol Metab 82:991-995
142. Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L, Cassiman JJ, Boonen S, Raus J, Geusens P 1999 Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. J Bone Miner Res 14:1576-1582
143. Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML 1998 Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939-944
144. Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH 2000 Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res 15:315-321
145. Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M 1998 Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695-705
146. Albagha OM, Pettersson U, Stewart A, McGuigan FE, MacDonald HM, Reid DM, Ralston SH 2005 Association of oestrogen receptor α gene polymorphisms with post-menopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42:240-246
147. Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A 2002 Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048-2060
148. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG 2004 Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105-2114
149. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodríguez R, Barbosa-Morais NL, Ponder BA, Low YL, Bingham S, Haiman CA, Le Marchand L, Broeks A, Schmidt MK, Hopper J, Southey M, Beckmann MW, Fasching PA, Peto J, Johnson N, Bojesen SE, Nordestgaard B, Milne RL, Benitez J, Hamann U, Ko Y, Schmutzler RK, Burwinkel B, Schürmann P, Dörk T, Heikkinen T, Nevanlinna H, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Chen X, Spurdle A, Change-Claude J, Flesch- Janys D, Couch FJ, Olson JE, Severi G, Baglietto L, Børresen-Dale AL, Kristensen V, Hunter DJ, Hankinson SE, Devilee P, Vreeswijk M, Lissowska J, Brinton L, Liu J, Hall P, Kang D, Yoo KY, Shen CY, Yu JC, Anton-Culver H, Ziogoas A, Sigurdson A, Struewing J, Easton DF, Garcia-Closas M, Humphreys MK, Morrison J, Pharoah PD, Pooley KA, Chenevix-Trench G 2009 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131-1139
150. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Meyers DA, Bleecker ER 2002 Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879-1882
151. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, Arai H, Yasuda M, Tanaka C, Emson PC, Nakamura S, Kawakami H 2000 Lack of an association of estrogen receptor α gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 57:236-240
152. Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, Levick JR, Burnand KG, Mortimer PS 2007 Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 115:1912-1920
153. Kim SH, Cho KW, Choi HS, Park SJ, Rhee Y, Jung HS, Lim SK 2009 The forkhead transcription factor Foxc2 stimulates osteoblast differentiation. Biochem Biophys Res Commun 386:532-536
154. Kaestner KH, Silberg DG, Traber PG, Schütz G 1997 The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation. Genes Dev 11:1583-1595
155. Iida K, Koseki H, Kakinuma H, Kato N, Mizutani-Koseki Y, Ohuchi H, Yoshioka H, Noji S, Kawamura K, Kataoka Y, Ueno F, Taniguchi M, Yoshida N, Sugiyama T, Miura N 1997 Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124:4627-4638
156. Bänziger C, Soldini D, Schütt C, Zipperlen P, Hausmann G, Basler K 2006 Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125:509-522
157. Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, Inoue S 2004 Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 22:341-345
158. Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS 2004 Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci 19:407-412
159. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE 2004 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74:866-875
160. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG 2006 Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21:141-150
161. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellström D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG 2008 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 299:1277-1290
162. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass 2nd DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314
163. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960-974
164. Ai M, Holmen SL, Van Hul W, Williams BO, Warman ML 2005 Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol 25:4946-4955
165. Kiel DP, Ferrari SL, Cupples LA, Karasik D, Manen D, Imamovic A, Herbert AG, Dupuis J 2007 Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 40:587-596
166. Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H 2007 Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res 22:1957-1967
167. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA 2003 Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998-2007
168. Malaval L, Wade-Guéye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux JP, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust MH, Amédée J, Vico L, Rossant J, Aubin JE 2008 Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205:1145-1153
169. Yoshitake H, Rittling SR, Denhardt DT, Noda M 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156-8160 (Pubitemid 29328424)
170. Bright NJ, Thornton C, Carling D 2009 The regulation and function of mammalian AMPK-related kinases. Acta Physiol (Oxf) 196:15-26
171. Riches PL, McRorie E, Fraser WD, Determann C, van't Hof R, Ralston SH 2009 Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med 361:1459-1465
172. Balemans W, Piters E, Cleiren E, Ai M, Van Wesenbeeck L, Warman ML, Van Hul W 2008 The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif Tissue Int 82:445-453
173. Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH, Van Hul W 2002 Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms. Bone 31:515-519 (Pubitemid 35175456)
174. Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME 2004 Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 75:1032-1045 (Pubitemid 39532072)
175. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29 (Pubitemid 34137009)
176. Tang Y, Katuri V, Dillner A, Mishra B, Deng CX, Mishra L 2003 Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 299:574-577 (Pubitemid 36135157)
177. Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee KM, Lee KH, Kang C, Cho DY, Kang D 2005 Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif Tissue Int 77:152-159
178. Koh JM, Park BL, Kim DJ, Kim GS, Cheong HS, Kim TH, Hong JM, Shin HI, Park EK, Kim SY, Shin HD 2007 Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women. Osteoporos Int 18:323-331 (Pubitemid 46233178)
179. Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, Li Z, Brain JD, Rosen CJ, Laird N, Xu X 2006 Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum Genet 118:568-577 (Pubitemid 41825129)
180. Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF 2002 Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245-1255 (Pubitemid 34680501)
181. Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL 2005 The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 16:1519-1524 (Pubitemid 41790855)
182. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL 2007 No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 40:175-181 (Pubitemid 44839322)
183. Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM 2007 Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 14:913-918
184. Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, Ala-Kokko L, Prockop DJ, Spotila LD 1998 First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6:151-157 (Pubitemid 28197339)
185. Devoto M, Specchia C, Li HH, Caminis J, Tenenhouse A, Rodriguez H, Spotila LD 2001 Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 10:2447-2452 (Pubitemid 33069550)
186. Nakanishi R, Shimizu M, Mori M, Akiyama H, Okudaira S, Otsuki B, Hashimoto M, Higuchi K, Hosokawa M, Tsuboyama T, Nakamura T 2006 Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J Bone Miner Res 21:1713-1721 (Pubitemid 46141226)
187. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I α 1 gene. Nat Genet 14:203-205 (Pubitemid 26338805)
188. Garnero P, Borel O, Grant SF, Ralston SH, Delmas PD 1998 Collagen I α 1 polymorphism, Bone mass and bone turnover in healthy French pre-menopausal women: the OFELY Study. J Bone Miner Res 13:813-817 (Pubitemid 28224197)
189. Langdahl BL, Ralston SH, Grant SF, Eriksen EF 1998 An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in men and women. J Bone Miner Res 13:1384-1389
190. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH 1998 Relation of alleles of the collagen type I α 1 gene to bone density and risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016-1021 (Pubitemid 28180402)
191. Roux C, Dougados M, Abel L, Mercier G, Lucotte G 1998 Association of a polymorphism in the collagen I α 1 gene with osteoporosis in French women. Arthritis Rheum 41:187-188
192. Alvarez L, Oriola J, Jo J, Ferró T, Pons F, Peris P, Guañabens N, Durán M, Monegal A, Martínez de Osaba MJ, Rivera-Fillat F, Ballesta AM 1999 Collagen type I α1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: improved detection of Sp1 binding site polymorphism in the collagen type 1 gene. Clin Chem 45:904-906 (Pubitemid 29266624)
193. Weichetová M, Stepán JJ, Michalská D, Haas T, Pols HA, Uitterlinden AG 2000 COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures. Bone 26:287-290 (Pubitemid 30101654)
194. McGuigan FE, Reid DM, Ralston SH 2000 Susceptibility to osteoporotic fracture is determined by allelic variation at the Sp1 site, rather than other polymorphic sites at the COL1A1 locus. Osteoporos Int 11:338-343
195. Braga V, Mottes M, Mirandola S, Lisi V, Malerba G, Sartori L, Bianchi G, Gatti D, Rossini M, Bianchini D, Adami S 2000 Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women. Calcif Tissue Int 67:361-366 (Pubitemid 32061168)
196. Keen RW, Woodford-Richens KL, Grant SF, Ralston SH, Lanchbury JS, Spector TD 1999 Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 42:285-290
197. Liu PY, Lu Y, Long JR, Xu FH, Shen H, Recker RR, Deng HW 2004 Common variants at the PCOL2 and Sp1 binding sites of the COL1A1 gene and their interactive effect influence bone mineral density in Caucasians. J Med Genet 41:752-757 (Pubitemid 39389291)
198. Efstathiadou Z, Kranas V, Ioannidis JP, Georgiou I, Tsatsoulis A 2001 The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int 12:326-331 (Pubitemid 34912740)
199. Pluijm SM, van Essen HW, Bravenboer N, Uitterlinden AG, Smit JH, Pols HA, Lips P 2004 Collagen type I α1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women. Ann Rheum Dis 63:71-77 (Pubitemid 38064607)
200. Ashford RU, Luchetti M, McCloskey EV, Gray RL, Pande KC, Dey A, Kayan K, Ralston SH, Kanis JA 2001 Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I α 1 alleles in elderly women. Calcif Tissue Int 68:348-351 (Pubitemid 32619303)
201. Berg JP, Lehmann EH, Stakkestad JA, Haug E, Halse J 2000 The Sp1 binding site polymorphism in the collagen type I α 1 (COLIA1) gene is not associated with bone mineral density in healthy children, adolescents, and young adults. Eur J Endocrinol 143:261-265 (Pubitemid 30622361)
202. Heegaard A, Jorgensen HL, Vestergaard AW, Hassager C, Ralston SH 2000 Lack of influence of collagen type Iα1 Sp1 binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years. Calcif Tissue Int 66:409-413 (Pubitemid 30368369)
203. Efstathiadou Z, Tsatsoulis A, Ioannidis JP 2001 Association of collagen Iα 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 16:1586-1592 (Pubitemid 32786427)
204. Mann V, Ralston SH 2003 Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 32:711-717 (Pubitemid 37297394)
205. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182 (Pubitemid 36177070)
206. Beavan S, Prentice A, Dibba B, Yan L, Cooper C, Ralston SH 1998 Polymorphism of the collagen type I α 1 gene and ethnic differences in hip-fracture rates. N Engl J Med 339:351-352 (Pubitemid 28366432)
207. Nakajima T, Ota N, Shirai Y, Hata A, Yoshida H, Suzuki T, Hosoi T, Orimo H, Emi M 1999 Ethnic difference in contribution of Sp1 site variation of COLIA1 gene in genetic predisposition to osteoporosis. Calcif Tissue Int 65:352-353 (Pubitemid 29514070)
208. Lau EM, Choy DT, Li M, Woo J, Chung T, Sham A 2004 The relationship between COLI A1 polymorphisms (Sp 1) and COLI A2 polymorphisms (Eco R1 and Puv II) with bone mineral density in Chinese men and women. Calcif Tissue Int 75:133-137 (Pubitemid 39166214)
209. Jin H, Stewart TL, Hof RV, Reid DM, Aspden RM, Ralston S 2009 A rare haplotype in the upstream regulatory region of COL1A1 is associated with reduced bone quality and hip fracture. J Bone Miner Res 24:448-454
210. Stewart TL, Roschger P, Misof BM, Mann V, Fratzl P, Klaushofer K, Aspden R, Ralston SH 2005 Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralisation in vivo. Calcif Tissue Int 77:113-118 (Pubitemid 41507199)
211. Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH 2001 A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899-907 (Pubitemid 32274043)
212. Jin H, van't Hof RJ, Albagha OM, Ralston SH 2009 Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Hum Mol Genet 18:2729-2738
213. Garcia-Giralt N, Nogués X, Enjuanes A, Puig J, Mellibovsky L, Bay-Jensen A, Carreras R, Balcells S, Díez-Pérez A, Grinberg D 2002 Two new single nucleotide polymorphisms in the COLIA1 upstream regulatory region and their relationship with bone mineral density. J Bone Miner Res 17:384-393 (Pubitemid 34171753)
214. Stewart TL, Jin H, McGuigan FE, Albagha OM, Garcia-Giralt N, Bassiti A, Grinberg D, Balcells S, Reid DM, Ralston SH 2006 Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. J Clin Endocrinol Metab 91:3575-3583 (Pubitemid 44402140)
215. García-Giralt N, Enjuanes A, Bustamante M, Mellibovsky L, Nogués X, Carreras R, Díez-Pérez A, Grinberg D, Balcells S 2005 In vitro functional assay of alleles and haplotypes of two COL1A1-promoter SNPs. Bone 36:902-908
216. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF 1997 A sequence variation: 713-8delC in the transforming growth factor-β 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20:289-294 (Pubitemid 27141842)
217. Bertoldo F, D'Agruma L, Furlan F, Colapietro F, Lorenzi MT, Maiorano N, Iolascon A, Zelante L, Locascio V, Gasparini P 2000 Transforming growth factor-β1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. J Bone Miner Res 15:634-639 (Pubitemid 30174017)
218. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K 1998 Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13:1569-1576 (Pubitemid 28465297)
219. Yamada Y, Hosoi T, Makimoto F, Tanaka H, Seino Y, Ikeda K 1999 Transforming growth factor β-1 gene polymorphism and bone mineral density in Japanese adolescents. Am J Med 106:477-479 (Pubitemid 29190603)
220. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Ohta H, Shiraki M 2000 Association of transforming growth factor β1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
221. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD 1999 Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93-97
222. McGuigan FE, Macdonald HM, Bassiti A, Farmer R, Bear S, Stewart A, Black A, Fraser WD, Welsh F, Reid DM, Ralston SH 2007 Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women. J Bone Miner Res 22:195-202
223. Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S, Brandi ML, Scollen S, Lips P, Lorenc R, Obermayer-Pietsch B, Reid DM, Armas JB, Arp PP, Bassiti A, Bustamante M, Husted LB, Carey AH, Pérez Cano R, Dobnig H, Dunning AM, Fahrleitner-Pammer A, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, Masi L, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, Mosekilde L, Nogués X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Ioannidis JP 2008 Large-scale analysis of association between polymorphisms in the transforming growth factor β1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 42:969-981
224. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J 1995 Abnormal lung development and cleft palate in mice lacking TGF-β 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421
225. Morrison NA, Yeoman R, Kelly PJ, Eisman JA 1992 Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 89:6665-6669
226. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles [Erratum (1997) 387:106]. Nature 367:284-287
227. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E 1997 A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12:915-921
228. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D 1998 The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 13:1691-1699
229. Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E 2001 The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16:1256-1264
230. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG 2003 Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632-1641
231. Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Reeve J, Reid DM, Amedei A, Amidei A, Bassiti A, Bustamante M, Husted LB, Diez-Perez A, Dobnig H, Dunning AM, Enjuanes A, Fahrleitner-Pammer A, Fang Y, Karczmarewicz E, Kruk M, van Leeuwen JP, Mavilia C, van Meurs JB, Mangion J, McGuigan FE, Pols HA, Renner W, Rivadeneira F, van Schoor NM, Scollen S, Sherlock RE, Ioannidis JP 2006 The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 145:255-264 (Pubitemid 46768609)
232. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA, Uitterlinden AG 2005 Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet 77:807-823
233. Krall EA, Parry P, Lichter JB, Dawson-Hughes B 1995 Vitamin D receptor alleles and rates of bone loss: influence of years since menopause and calcium intake. J Bone Miner Res 10:978-984
234. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP 1995 Vitamin D receptor gene polymorphisms and change in lumbar spine bone mineral density. Lancet 345:423-424
235. Graafmans WC, Lips P, Ooms ME, van Leeuwen JP, Pols HA, Uitterlinden AG 1997 The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 12:1241-1245
236. Dawson-Hughes B, Harris SS, Finneran S 1995 Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80:3657-3661
237. Gennari L, Becherini L, Masi L, Gonnelli S, Cepollaro C, Martini S, Mansani R, Brandi ML 1997 Vitamin D receptor genotypes and intestinal calcium absorption in post-menopausal women. Calcif Tissue Int 61:460-463
238. Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G 1995 Vitamin D receptor gene polymorphism, bone mass, body size and mucosal VDR density. Calcif Tissue Int 57:161-162
239. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA 1999 Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14:740-746
240. Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RJ, Ellis KJ 2005 Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20:945-953
241. Zmuda JM, Cauley JA, Danielson ME, Theobald TM, Ferrell RE 1999 Vitamin D receptor translation initiation codon polymorphism and markers of osteoporotic risk in older African-American women. Osteoporos Int 9:214-219
242. Macdonald HM, McGuigan FE, Stewart A, Black AJ, Fraser WD, Ralston S, Reid DM 2006 Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res 21:151-162
243. Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Kindmark A, Mallmin H 2003 A poly adenosine repeat in the human vitamin D receptor gene is associated with bone mineral density in young Swedish women. Calcif Tissue Int 73:455-462
244. Verbeek W, Gombart AF, Shiohara M, Campbell M, Koeffler HP 1997 Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem Biophys Res Comm 238:77-80
245. Grundberg E, Lau EM, Pastinen T, Kindmark A, Nilsson O, Ljunggren O, Mellström D, Orwoll E, Redlund-Johnell I, Holmberg A, Gurd S, Leung PC, Kwok T, Ohlsson C, Mallmin H, Brändström H 2007 Vitamin D receptor 3′ haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J Bone Miner Res 22:832-840
246. Mocharla H, Butch AW, Pappas AA, Flick JT, Weinstein RS, De Togni P, Jilka RL, Roberson PK, Parfitt AM, Manolagas SC 1997 Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 12:726-733
247. Gross C, Musiol IM, Eccleshall TR, Malloy PJ, Feldman D 1998 Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Biochem Biophys Res Comm 242:467-473
248. Durrin LK, Haile RW, Ingles SA, Coetzee GA 1999 Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta 1453:311-320
249. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR 2000 The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14:401-420
250. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HA, van Leeuwen JP 2000 Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52:211-216
251. Uitterlinden AG, Weel AE, Burger H, Fang Y, van Duijn CM, Hofman A, van Leeuwen JP, Pols HA 2001 Interaction between the vitamin D receptor gene and collagen type Iα1 gene in susceptibility for fracture. J Bone Miner Res 16:379-385
252. Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beck TJ, Arp P, Schuit SC, Hofman A, Houwing-Duistermaat JJ, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG 2006 Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21:1443-1456
253. Roses AD 2000 Pharmacogenetics and the practice of medicine. Nature 405:857-865
254. Ongphiphadhanakul B, Chanprasertyothin S, Payatikul P, Tung SS, Piaseu N, Chailurkit L, Chansirikarn S, Puavilai G, Rajatanavin R 2000 Oestrogen-receptor-α gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women. Clin Endocrinol (Oxf) 52:581-585
255. Han K, Choi J, Moon I, Yoon H, Han I, Min H, Kim Y, Choi Y 1999 Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporos Int 9:290-295 (Pubitemid 29216762)
256. Heikkinen AM, Kröger H, Niskanen L, Komulainen MH, Ryynänen M, Parviainen MT, Tuppurainen MT, Honkanen R, Saarikoski S 2000 Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women? Maturitas 34:33-41
257. Marc J, Prezelj J, Komel R, Kocijancic A 1999 VDR genotype and response to etidronate therapy in late post-menopausal women. Osteoporos Int 10:303-306 (Pubitemid 29476194)
258. Qureshi AM, Herd RJ, Blake GM, Fogelman I, Ralston SH 2002 COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy. Calcif Tissue Int 70:158-163 (Pubitemid 36929595)
259. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP 2008 Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40:592-599 (Pubitemid 351601207)
260. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-872 (Pubitemid 39038422)
261. Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, Chen Y, Zhang ZX, Dong SS, Xu XH, Yan H, Liu X, Qiu C, Zhu XZ, Chen T, Li M, Zhang H, Zhang L, Drees BM, Hamilton JJ, Papasian CJ, Recker RR, Song XP, Cheng J, Deng HW 2008 Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet 83:663-674
262. Kung AW, Xiao SM, Cherny S, Li GH, Gao Y, Tso G, Lau KS, Luk KD, Liu JM, Cui B, Zhang MJ, Zhang ZL, He JW, Yue H, Xia WB, Luo LM, He SL, Kiel DP, Karasik D, Hsu YH, Cupples LA, Demissie S, Styrkarsdottir U, Halldorsson BV, Sigurdsson G, Thorsteinsdottir U, Stefansson K, Richards JB, Zhai G, Soranzo N, Valdes A, Spector TD, Sham PC 2010 Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet 86:229-239